55 participants
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-01
- Start Date:
- 2026-02-09
- Completion:
- 2031-07-08
Conditions
- Bladder Cancer
Interventions
- DRUG
- BIOLOGICAL
No Results Yet